A STUDY TO EVALUATE LUMRETUZUMAB IN COMBINATION WITH PERTUZUMAB AND PACLITAXEL IN PARTICIPANTS WITH METASTATIC BREAST CANCER EXPRESSING HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR (HER) 3 AND HER2 PROTEIN: